Home LiteratureArticle Details
PMID: 6694739 Published · ppublish English Journal Article

Retinoblastoma--origin from a primitive neuroectodermal cell?

Nature ·Vol. 307 ·No. 5950 ·1984-00-00 ·Pages 471-3

Kyritsis AP, Tsokos M, Triche TJ, Chader GJ

Abstract

The histogenesis of retinoblastoma, the most common intraocular neoplasm of childhood, remains controversial. Previous studies have attributed the origin of the tumour to neuronal, glial or primitive stem cells of retina. In the study described here we have used immunofluorescence to search for the presence of a neuronal marker, neurone-specific enolase (NSE) and a glial marker, glial fibrillary acidic protein (GFAP), in the cells of the human retinoblastoma line Y-79 (ref. 4), before and after successful differentiation into neuronal and glial-like cells. We found that all undifferentiated cells contain both NSE and GFAP, whereas the differentiating neuronal and glial-like cells gradually lose one marker and selectively express the marker that correlates with their morphology. Our results support the notion that retinoblastoma originates from a primitive bipotential (or multipotential) neuroectodermal cell.

MeSH Terms
Cell Differentiation Cell Line Ectoderm/cytology Humans Intermediate Filament Proteins/metabolism Neuroglia/pathology Neurons/pathology Phosphopyruvate Hydratase/metabolism Retinoblastoma/pathology
Chemicals
Intermediate Filament Proteins Phosphopyruvate Hydratase
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Kyritsis A P
Tsokos M
Triche T J
Chader G J
Article Info
Journal
Nature
Abbr.
Nature
ISSN
0028-0836
Published
1984-00-00
Pages
471-3
Language
English
Region
England
NLM ID
0410462
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com